AVBPArriVent BioPharma, Inc.
$21.02+7.1% 1Y
$21.02
$15.1252 weeks$34.75
The financials
ArriVent BioPharma, Inc. by the numbers
The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$53M | −$34M | n/a |
| Net income | −$50M | −$31M | n/a |
| Diluted EPS | −$1.05 | −$0.90 | n/a |
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry